|
|||||
|
|
Attenuated Salmonella VNP20009 mutant (ΔhtrA) is a promising candidate for bacteria‐mediated tumour therapy in hosts with TNFR1 deficiency |
|
| Authors: | W. Xu T. Zhou J. Zhou Z. Qiang J. Zhang Z. Hua |
| Affiliation: | 1. The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China;2. Changzhou High‐Tech Research Institute of Nanjing University and Jiangsu TargetPharma Laboratories Inc., Changzhou, China;3. Shenzhen Research Institute of Nanjing University, Shenzhen, China |
| Abstract: | |
| Keywords: | htrA Salmonella TNFR1 tumour treatment VNP20009 |